Inhibition of anaplastic lymphoma kinase (ALK) activity provides a therapeutic approach for CLTC-ALK-positive human diffuse large B cell lymphomas

author
created [InstanceEdit:9710764] Rothfels, Karen, 2021年01月05日
dbId 9710767
displayName Inhibition of anaplastic lymphoma kinase (ALK) activity provides a therapeutic approach for CLTC-ALK-positive human diffuse large B cell lymphomas
journal PLoS One
pages e18436
pubMedIdentifier 21494621
schemaClass LiteratureReference
title Inhibition of anaplastic lymphoma kinase (ALK) activity provides a therapeutic approach for CLTC-ALK-positive human diffuse large B cell lymphomas
url http://www.ncbi.nlm.nih.gov/pubmed/21494621
volume 6
year 2011
Cite Us!

AltStyle によって変換されたページ (->オリジナル) /